StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

Stock analysts at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a report issued on Thursday. The brokerage set a “hold” rating on the stock.

ObsEva Price Performance

The stock’s fifty day simple moving average is $0.01. ObsEva has a one year low of $0.08 and a one year high of $2.14. The firm has a market cap of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.